NATH BIOGENES (INDIA)
Back to Cashflow Statement
|
NATH BIOGENES (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹18 Cr | ₹75 Cr | ₹38 Cr | ₹17 Cr | ₹14 Cr |
What is the latest Cash Flow from Operating Activities ratio of NATH BIOGENES (INDIA) ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹75 Cr |
| Mar2023 | ₹38 Cr |
| Mar2022 | ₹17 Cr |
| Mar2013 | ₹14 Cr |
How is Cash Flow from Operating Activities of NATH BIOGENES (INDIA) Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | -76.43 | |
| Mar2024 | ₹75 Cr | 94.42 | |
| Mar2023 | ₹38 Cr | 125.05 | |
| Mar2022 | ₹17 Cr | 19.96 | |
| Mar2013 | ₹14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹302.3 Cr | 4% | 0.3% | -20.9% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹13,213.0 Cr | 0.2% | 1.8% | -16.7% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,098.1 Cr | 2.7% | 4.3% | 6.5% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,043.9 Cr | -0.4% | 7.7% | -23.6% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,050.6 Cr | -1.8% | -10.9% | -32.6% | Stock Analytics | |
| INDO US BIOTECH | ₹242.4 Cr | -3.3% | 3.7% | -63.3% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 4% |
0.3% |
-20.9% |
| SENSEX | 1% |
0.3% |
6.7% |
You may also like the below Video Courses